NSCLC (non-small cell lung cancer)R

Clinical trials for NSCLC (non-small cell lung cancer)R explained in plain language.

Never miss a new study

Get alerted when new NSCLC (non-small cell lung cancer)R trials appear

Sign up with your email to follow new studies for NSCLC (non-small cell lung cancer)R, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

LPR-2: a prospective, single-center, non-randomized, interventional study on the effectiveness and safety of combined immunotargeted therapy in patients with metastatic non-small cell cancer with a RET gene translocation

Recruiting now

This interventional study will evaluate the effectiveness, safety, and tolerability of pembrolizumab in combination with lenvatinib in adults with metastatic non-small cell lung cancer (NSCLC) who have a confirmed RET gene rearrangement and whose disease has progressed after one …

Matched conditions: NSCLC (NON-SMALL CELL LUNG CANCER)R

Phase 3 • Sponsor: EuroCityClinic LLC

Last updated Sep 09, 2026 19:00 UTC

NSCLC (non-small cell lung cancer)R

Get alerted when new NSCLC (non-small cell lung cancer)R trials appear

LPR-2: a prospective, single-center, non-randomized, interventional study on the effectiveness and safety of combined immunotargeted therapy in patients with metastatic non-small cell cancer with a RET gene translocation